Bain Capital Life Sciences Investors, LLC

Insider Buys Quantity –
8
2023-05-25PurchaseAnnexon, Inc.
ANNX
10 percent owner
300,000
0.4125%
$2.13$639,720+64.76%
2021-12-10PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
25,000
0.0858%
$9.65$241,202-70.24%
2021-12-09PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
4,011
0.0145%
$9.84$39,485-69.23%
2021-12-08PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
13,458
0.0484%
$9.62$129,474-68.51%
2021-07-19PurchaseRapid Micro Biosystems, Inc.
RPID
10 percent owner
100,000
0.2804%
$20.00$2M-59.26%
2020-07-28PurchaseAnnexon, Inc.
ANNX
10 percent owner
800,000
2.6558%
$17.00$13.6M+33.07%
2020-02-04PurchaseArcutis Biotherapeutics, Inc.
ARQT
10 percent owner
588,234
1.6079%
$17.00$10M+5.03%
2018-07-24PurchaseReplimune Group, Inc.
REPL
10 percent owner
1M
4.0424%
$15.00$15M-7.15%
2017-12-19SaleMarinus Pharmaceuticals, Inc.
MRNS
10 percent owner
300,000
0.3633%
$3.72$1.11M-21.32%
2017-12-18SaleMarinus Pharmaceuticals, Inc.
MRNS
10 percent owner
600,000
0.7827%
$3.75$2.25M-15.65%
2017-12-15SaleMarinus Pharmaceuticals, Inc.
MRNS
10 percent owner
1.65M
2.0904%
$4.05$6.66M-23.64%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us